BlackRock Investment Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

BlackRock Investment Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$597K	Buy	31,662 +6,027	+24%	+$147K	﹤0.01%	2979
2016 Q3	$769K	Buy	25,635 +320	+1%	+$9.96K	﹤0.01%	2824
2016 Q2	$973K	Buy	25,315 +20,630	+440%	+$856K	﹤0.01%	2662
2016 Q1	$178K	Sell	4,685 -1,391	-23%	-$48.5K	﹤0.01%	3184
2015 Q4	$267K	Buy	6,076 +193	+3%	+$9.57K	﹤0.01%	3176
2015 Q3	$239K	Sell	5,883 -747	-11%	-$32.8K	﹤0.01%	3213
2015 Q2	$354K	Buy	6,630 +3,583	+118%	+$190K	﹤0.01%	3205
2015 Q1	$185K	Sell	3,047 -5,653	-65%	-$274K	﹤0.01%	3232
2014 Q4	$454K	Buy	+8,700	New	+$389K	﹤0.01%	3056

Other funds holding JUNO

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BCM

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BlackRock Investment Management's JUNO Position: Q4 2016 in Review

BlackRock Investment Management increased its Juno Therapeutics, Inc. (JUNO) stake by 24% in Q4 2016, buying an estimated $147K and bringing the position to 31,662 shares worth $597K. The position accounts for ﹤0.01% of the portfolio, ranked #2979.

BlackRock Investment Management first reported a position in JUNO in Q4 2014 and has held it in 9 quarters since. The position peaked at $973K in Q2 2016. 159 funds tracked by Wall St. Rank hold JUNO as of Q4 2016.

BlackRock Investment Management held 31,662 shares of Juno Therapeutics, Inc. worth $597K as of Q4 2016.
BlackRock Investment Management bought 6,027 Juno Therapeutics, Inc. shares in Q4 2016, an estimated $147K.
Juno Therapeutics, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2979 holding.
BlackRock Investment Management first reported a position in Juno Therapeutics, Inc. in Q4 2014 and has held it in 9 quarters since.
BlackRock Investment Management's Juno Therapeutics, Inc. position peaked at $973K in Q2 2016.
159 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.